FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4280493280> ?p ?o ?g. }

• W4280493280 endingPage "904" @default.
• W4280493280 startingPage "897" @default.
• W4280493280 abstract "Objectives To investigate the effects of pretreatment with 5‐aminolevulinic acid hydrochloride combined with sodium ferrous citrate on bladder dysfunction in cyclophosphamide‐induced hemorrhagic cystitis in rats. Methods Male Wistar rats (340–460 g) were pretreated with vehicle or with 5‐aminolevulinic acid hydrochloride combined with sodium ferrous citrate (100/157 or 300/471 mg/kg/day, po) once daily for 7 days before cystometry. Saline or cyclophosphamide (150 mg/kg, ip) was administered 2 days before cystometry. Cystometry was performed under urethane anesthesia (0.8 g/kg, ip) via a catheter inserted into the bladder. After cystometry, bladder tissues were collected to perform hematoxylin and eosin staining for pathological evaluation (neutrophil infiltration, edema, and bleeding scores), and for enzyme‐linked immunosorbent assay and real‐time polymerase chain reaction for investigating tissue levels of myeloperoxidase, and mRNA levels of haem oxygenase‐1 as a cytoprotective molecule. Results Compared to controls, cyclophosphamide induced a shorter intercontraction interval, lower bladder compliance, increased number of non‐voiding contractions, and increased pathological scores and myeloperoxidase expression in the bladder. Pretreatment with 5‐aminolevulinic acid hydrochloride combined with sodium ferrous citrate (300/471 mg/kg/day) significantly improved cyclophosphamide‐induced intercontraction interval shortening and increases in number of non‐voiding contractions and neutrophil infiltration/bleeding scores and enhanced haem oxygenase‐1 expression in the bladder. In addition, cyclophosphamide‐induced decreases in bladder compliance and increases in myeloperoxidase were not detected with 5‐aminolevulinic acid hydrochloride combined with sodium ferrous citrate pretreatment. Conclusions Pretreatment with 5‐aminolevulinic acid expects protective effects on bladder dysfunction in cyclophosphamide‐induced hemorrhagic cystitis by improving inflammatory changes in bladder tissues perhaps via up‐regulation of haem oxygenase‐1." @default.
• W4280493280 created "2022-05-22" @default.
• W4280493280 creator A5003164127 @default.
• W4280493280 creator A5018034301 @default.
• W4280493280 creator A5022278363 @default.
• W4280493280 creator A5022421825 @default.
• W4280493280 creator A5029203922 @default.
• W4280493280 creator A5058891775 @default.
• W4280493280 creator A5064464692 @default.
• W4280493280 creator A5070296954 @default.
• W4280493280 creator A5091422162 @default.
• W4280493280 date "2022-05-18" @default.
• W4280493280 modified "2023-09-26" @default.
• W4280493280 title "<scp>5‐Aminolevulinic</scp> acid has the potential to prevent bladder dysfunction in cyclophosphamide‐induced hemorrhagic cystitis" @default.
• W4280493280 cites W1529447899 @default.
• W4280493280 cites W1598488379 @default.
• W4280493280 cites W1886262751 @default.
• W4280493280 cites W1916800927 @default.
• W4280493280 cites W1971030831 @default.
• W4280493280 cites W1979465512 @default.
• W4280493280 cites W1981224218 @default.
• W4280493280 cites W1982237383 @default.
• W4280493280 cites W1997021368 @default.
• W4280493280 cites W2004294769 @default.
• W4280493280 cites W2032009151 @default.
• W4280493280 cites W2083415995 @default.
• W4280493280 cites W2107277218 @default.
• W4280493280 cites W2125464507 @default.
• W4280493280 cites W2144466949 @default.
• W4280493280 cites W2163837379 @default.
• W4280493280 cites W2176657613 @default.
• W4280493280 cites W2177848913 @default.
• W4280493280 cites W2337532078 @default.
• W4280493280 cites W2520136862 @default.
• W4280493280 cites W2578328514 @default.
• W4280493280 cites W2590481391 @default.
• W4280493280 cites W2598356084 @default.
• W4280493280 cites W2739940592 @default.
• W4280493280 cites W2799452757 @default.
• W4280493280 cites W2803296974 @default.
• W4280493280 cites W2896621286 @default.
• W4280493280 cites W2922757272 @default.
• W4280493280 cites W2947115927 @default.
• W4280493280 cites W2990643502 @default.
• W4280493280 cites W3006075601 @default.
• W4280493280 cites W3015782948 @default.
• W4280493280 cites W3143648151 @default.
• W4280493280 doi "https://doi.org/10.1111/iju.14928" @default.
• W4280493280 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/35582850" @default.
• W4280493280 hasPublicationYear "2022" @default.
• W4280493280 type Work @default.
• W4280493280 citedByCount "1" @default.
• W4280493280 countsByYear W42804932802023 @default.
• W4280493280 crossrefType "journal-article" @default.
• W4280493280 hasAuthorship W4280493280A5003164127 @default.
• W4280493280 hasAuthorship W4280493280A5018034301 @default.
• W4280493280 hasAuthorship W4280493280A5022278363 @default.
• W4280493280 hasAuthorship W4280493280A5022421825 @default.
• W4280493280 hasAuthorship W4280493280A5029203922 @default.
• W4280493280 hasAuthorship W4280493280A5058891775 @default.
• W4280493280 hasAuthorship W4280493280A5064464692 @default.
• W4280493280 hasAuthorship W4280493280A5070296954 @default.
• W4280493280 hasAuthorship W4280493280A5091422162 @default.
• W4280493280 hasConcept C126322002 @default.
• W4280493280 hasConcept C126894567 @default.
• W4280493280 hasConcept C203565725 @default.
• W4280493280 hasConcept C2776694085 @default.
• W4280493280 hasConcept C2776755627 @default.
• W4280493280 hasConcept C2776914184 @default.
• W4280493280 hasConcept C2777600175 @default.
• W4280493280 hasConcept C2779762690 @default.
• W4280493280 hasConcept C2780080261 @default.
• W4280493280 hasConcept C71924100 @default.
• W4280493280 hasConcept C98274493 @default.
• W4280493280 hasConceptScore W4280493280C126322002 @default.
• W4280493280 hasConceptScore W4280493280C126894567 @default.
• W4280493280 hasConceptScore W4280493280C203565725 @default.
• W4280493280 hasConceptScore W4280493280C2776694085 @default.
• W4280493280 hasConceptScore W4280493280C2776755627 @default.
• W4280493280 hasConceptScore W4280493280C2776914184 @default.
• W4280493280 hasConceptScore W4280493280C2777600175 @default.
• W4280493280 hasConceptScore W4280493280C2779762690 @default.
• W4280493280 hasConceptScore W4280493280C2780080261 @default.
• W4280493280 hasConceptScore W4280493280C71924100 @default.
• W4280493280 hasConceptScore W4280493280C98274493 @default.
• W4280493280 hasIssue "8" @default.
• W4280493280 hasLocation W42804932801 @default.
• W4280493280 hasLocation W42804932802 @default.
• W4280493280 hasOpenAccess W4280493280 @default.
• W4280493280 hasPrimaryLocation W42804932801 @default.
• W4280493280 hasRelatedWork W188685642 @default.
• W4280493280 hasRelatedWork W1965501096 @default.
• W4280493280 hasRelatedWork W1981247351 @default.
• W4280493280 hasRelatedWork W2185915241 @default.
• W4280493280 hasRelatedWork W2326320326 @default.
• W4280493280 hasRelatedWork W2353517647 @default.
• W4280493280 hasRelatedWork W2412787941 @default.
• W4280493280 hasRelatedWork W2760115396 @default.

• next